THE COPPER INDEX · FORMULAS UNDER THE LENSRESEARCHED OCTOBER 2026
Cucopper indexFIVE FORMULAS. CLOSER READING.
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
COMPOUNDED CREAM

CoreAge Rx Bounce Back review

A copper-peptide cream offered through clinical review, with a public concentration discrepancy that needs resolving.

Price
From $64.99/month
Strength
2% on product page; 0.2% in help catalog
Access
Prescription after assessment

Do not treat the published percentages as interchangeable

The Bounce Back page names a copper-peptide cream and emphasizes visible firmness and recovery. Its ingredient panel and FAQ describe 2%. The help catalog lists 0.2% for the same name. Neither source establishes that the two descriptions refer to different currently available variants.[source][source]

The practical next step is to request the prescription’s exact peptide, concentration and full base. This review deliberately leaves that question open. A tenfold numerical difference cannot be dismissed as a formatting choice without confirmation.

A rationale is different from a measured result

Copper peptides have a research history, but a mechanism proposed for an ingredient does not quantify the visible effect of this dispensed blend. We did not find an independently verified comparison demonstrating that Bounce Back improves wrinkles more than the other products.

The monthly service may offer access to a clinician, which can be relevant when someone already uses other active skincare. That service value should be assessed through the available clinical contact and follow-up terms, rather than assumed from an ingredient claim.

Questions to settle before the first payment

The dedicated page advertises a $64.99 monthly starting point, no membership fee and free delivery. Ask which supply period that price buys, what is charged immediately and how a declined prescription is handled.[source][source]

Also ask about instructions after a procedure, on irritated skin or alongside prescribed treatments. The product’s recovery language should not be converted into a self-directed wound-care plan. Compounded status does not mean FDA approval of this finished medicine.[source]

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.

  1. CoreAge Rx: Bounce BackCurrent page advertises 2% and from $64.99/month
  2. CoreAge Rx: help catalogCatalog instead lists 0.2%; discrepancy remains unresolved
  3. FDA: compounding questions and answersOfficial source; checked October 8, 2026

Keep reading